Shpro (Mixture of Angelica Gigas and Astragalus Membranaceus) in Men with Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

January 2025 in “ Investigative and Clinical Urology ”

Ji Hun Lee, Dahye Yoon, Geum Duck Park, Kyung Seok Kim, Soo Ro Kim, Woo Cheol Shin, Seung Hwan Lee, Dae‐Young Lee

TLDR SHPro® improved urinary symptoms and erectile function in men and is safe.

A 12-week randomized, double-blind, placebo-controlled clinical trial investigated the effects of SHPro® (a mixture of Angelica gigas and Astragalus membranaceus) on men with lower urinary tract symptoms. The study found that participants experienced improvements in total and incomplete emptying International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF), indicating subjective improvements. The safety of SHPro® was also confirmed.

View this study on icurology.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Risks And Side Effects In The Medical Management Of Benign Prostatic Hyperplasia

26 citations , December 2023 in “Prostate International”

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

research Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia

20 citations , August 2018 in “The World Journal of Men's Health”

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

research The Clinical Development of a 5α-Reductase Inhibitor, Finasteride

211 citations , November 1990 in “The Journal of Steroid Biochemistry and Molecular Biology”

Finasteride effectively treats BPH, but needs more trials to understand potential.